beta 2-adrenergic agonists exhibit antipermeability effects in the airways. However, it is not known whether beta 2-agonists have this beneficial effect in airway mucosa that is already inflamed. We evaluated the effects of two inhaled beta 2-agonists,
salbutamol and
formoterol, on the
histamine-induced bronchoconstriction and plasma extravasation in the airways of guinea pigs with or without
ozone exposure. Total pulmonary resistance (RL) was measured before and after
histamine inhalation in anesthetized animals that were pretreated with inhaled
salbutamol,
formoterol, or saline. Plasma extravasation in the airways was measured using
Evans blue dye. In the control animals not exposed to
ozone,
salbutamol and
formoterol each significantly reduced both the
histamine-induced bronchoconstriction and the plasma extravasation in the trachea and main bronchi. In the
ozone-exposed animals, the increase in RL after
histamine was greater than that in control animals.
Salbutamol and
formoterol each significantly reduced
histamine-induced bronchoconstriction, even in the
ozone-exposed animals.
Salbutamol did not affect the
histamine-induced plasma extravasation, whereas
formoterol reduced the plasma extravasation in the main bronchi, but not in the trachea, of the animals exposed to
ozone. These results suggest that the anti-inflammatory properties of
formoterol in inflamed airways may contribute to the beneficial effects in the treatment of airway
inflammation.